Healthcare Press Releases

Harford County Urologists Host Seminar About Prostate Cancer and Prostate Health

Local urologists Harne, Song and Woo, MD, PA, of Bel Air Urology announce their upcoming Prostate Cancer Educational Seminar to be held at their Harford County Urology office at 2007 Rock Spring Road, Forest Hill, on Monday, September 22nd at 6:00 – 7:30 PM. Light refreshments will be provided and attendees are urged to RSVP to 410-879-4879.

Teller County's First Medical Directory Now Available

Pikes Peak Regional Medical Center Association (PPRMCA) announced today that the 2014 Teller County Medical Directory is available for the public, businesses and medical professionals.

Detailed Review of the Venus Factor Diet & Workout by Health Blog Exposes the Ultimate Body Program Designed by John Barban to Get the Perfect Feminine Figure

John Barban’s Venus Factor weight loss program has been proved effective for all women who tried it. The fitness program works on all breakthrough tips combined in a single package to help women lose weight unless they gain their desired body shape. John Barban has focused women as most of them need to struggle more as compared to men. Women physique is controlled in a different manner than men but can be brought back into shape if adequate research is conducted, John believed. He launched “The Venus Factor” package in the market to help out women before they lose hope. And many of them have even regained their hope and confidence with the Venus factor weight management program as reviewed by users.

New Market Research Report: Wound Care in Chile

LogoWound treatments are one of the basic items people buy to put in medicine cabinets. In fact, as there is a daily risk of minor incidents occurring, especially for children, households tend to have their own first aid materials. In addition to households, companies and schools have increased their demand for wound care as they are required by law to have first aid treatments and inspections have been tighter of late. Therefore, it is safe to argue that demand for wound care products is constant...

New Market Report Now Available: Profectus BioSciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

LogoMarketLines' Profectus BioSciences, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Profectus BioSciences, Inc. since January 2007. These reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

New Report Available: Sports Nutrition in Dominican Republic

LogoSports nutrition is an extremely niche category. Only a very narrow, higher-income, young, physically active audience is attracted by the category, which translated to just Do$30 million in 2013. The category growth's trend remains in that niche of higher-income athletes/muscle builders. This limited positioning is not allowing the category to enjoy its full potential.

Herbal/Traditional Products in Chile - New Market Report

LogoIn context of the review period, Chilean consumers still perceive herbal/traditional products to be safe and efficient, as herbal/traditional products are made from herbs and traditional plants which are reputed to cure diseases. In addition, herbal/traditional products do not contain chemicals which could give adverse side effects to users. This proves that the increasingly sophisticated consumers are more concerned about the impact of food intake on the body. There is a general perception...

Herbal/Traditional Products in Finland: New Research Report Available at Fast Market Research

LogoThe European Commission accepted two health claims for melatonin in May 2012: melatonin helps to relieve jet lag and reduces the time it takes to fall asleep. Previously there had been considerable confusion, withdrawals and disputes over these products sold outside pharmacy channels, while FIMEA classified them as medicine. In November 2013, FIMEA announced that it would allow products with 0.5-1mg of melatonin to be sold as dietary supplements. This was expected by vitamins and dietary...

New Market Study, "Analgesics in Mexico", Has Been Published

LogoIn 2013 combination products - analgesics had the biggest value share of analgesics with Mx$967 million. The leading brands in this category include Sedalmerck (Merck-Mexico SA), Bio-Electro (Genomma Lab Internacional SAB de CV) and Tylex (Johnson & Johnson de Mexico SA de CV). The popularity of these brands is explained by their good positioning due to heavy investments in advertising.

Population Health Management Market - Trends & Global Forecasts to 2018: New Research Report Available at Fast Market Research

LogoPopulation Health Management Market by Component (Software & Services), Delivery Mode (On-premise, Web, & Cloud), End-User (Provider, Payer, Employer Groups & Government Bodies) - Trends & Global Forecasts to 2018

Market Report, "Dermatologicals in Malaysia", Published

LogoHigher education level and better knowledge about dermatological diseases made consumers more comfortable with seeking self-medication. Dermatologicals recorded good growth of over 3% in 2013, which was just slightly slower than the review period's CAGR due to market maturation.

New Market Study, "Adult Mouth Care in Malaysia", Has Been Published

LogoBusier and more hectic lifestyles, together with the habit of eating oily and spicy food amongst Malaysian consumers, led to high prevalence of gum and mouth diseases, including mouth ulcers, periodontal diseases and others. As a result, adult mouth care continued to record stable growth in 2013.

"Cough, Cold and Allergy (Hay Fever) Remedies in Finland" Now Available at Fast Market Research

LogoCough, cold and allergy (hay fever) remedies recorded a slow current value sales increase by 1% in 2013, undermined by poor sales in the large antihistamines/allergy remedies category. Record low pollen levels during the spring and summer of 2013 resulted in lower demand for antihistamines/allergy remedies. However, the review period saw rather dynamic growth, up 24% in current value terms between 2008 and 2013. Increasing sales were driven by a growing self-medication trend. The growing...

Market Report, "Vitamins and Dietary Supplements in Turkey", Published

LogoVitamins and dietary supplements recorded 9% current value growth in 2013. Oncologists, dieticians and orthopedicians often recommend vitamins and dietary supplements, benefiting overall growth over the review period. Moreover, the establishment of "Family Doctors", a nationwide system designed to provide personal healthcare, allowing households to have free doctors' appointments in small clinics, so-called Saglik Ocagi in every neighbourhood, benefited vitamins and dietary supplements, as such...

"Wound Care in Malaysia" Is Now Available at Fast Market Research

LogoWound care continued to record good growth in 2013 with almost 3% in retail value. Many wound care products, such as plasters/bandages, gauze and tape, were considered necessities for most households. Many people kept stock of these products at home to use when the need arose. Most consumers were more familiar with the usage of plasters/bandages, whilst other products like first aid kits, gauze and tape were less popular as some people did not know how to use them in the correct way.

New Market Research Report: Antidepressants (Migraine) - Forecast and Market Analysis to 2023

LogoThe migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies are anticipated to launch during the forecast period and these will contribute to the market growth. By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but opportunities will remain for further treatment choices especially drugs that will offer an improved safety and side-effects profile.

T-Cell Lymphomas - Pipeline Review, H1 2014 - New Market Research Report

LogoT-Cell Lymphomas - Pipeline Review, H1 2014

Market Report, "Renal Cell Carcinoma - Pipeline Review, H1 2014", Published

LogoRenal Cell Carcinoma - Pipeline Review, H1 2014

Market Report, "Vascular Biogenics Ltd. - Product Pipeline Review - 2014", Published

LogoVascular Biogenics Ltd. - Product Pipeline Review - 2014

Recently Released Market Study: Cardiolynx AG - Product Pipeline Review - 2014

LogoCardiolynx AG - Product Pipeline Review - 2014

Osteosarcoma - Pipeline Review, H1 2014 - New Market Study Published

LogoOsteosarcoma - Pipeline Review, H1 2014

Mymetics Corporation - Product Pipeline Review - 2014 - New Market Study Published

LogoMymetics Corporation - Product Pipeline Review - 2014

New Market Report: Pneumonia Partnering 2009-2014

LogoThe Pneumonia Partnering 2009-2014 report provides understanding and access to the pneumonia partnering deals and agreements entered into by the worlds leading healthcare companies.

Now Available: Purdue Pharma L.P. - Product Pipeline Review - 2014

LogoPurdue Pharma L.P. - Product Pipeline Review - 2014

Dialysis Partnering 2009-2014: New Research Report Available at Fast Market Research

LogoThe Dialysis Partnering 2009-2014 provides understanding and access to the dialysis partnering deals and agreements entered into by the worlds leading healthcare companies.

New Market Study, "Sumavel DosePro (Migraine) - Forecast and Market Analysis to 2023", Has Been Published

LogoThe migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies are anticipated to launch during the forecast period and these will contribute to the market growth. By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but opportunities will remain for further treatment choices especially drugs that will offer an improved safety and side-effects profile.

"Insulin Resistance Global Clinical Trials Review, H1, 2014" Now Available at Fast Market Research

LogoGlobalData's clinical trial report, "Insulin Resistance Global Clinical Trials Review, H1, 2014" provides data on the Insulin Resistance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Insulin Resistance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Insulin Resistance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.